Log In
person
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount | Percentage |
| CDMO |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
92 | 5.41% |
| Domestic Preparation |
Pharmaceuticals and Active Ingredients for Pharmaceuticals
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
358 | 21.05% |
| Other |
Pharmaceuticals and Active Ingredients for Pharmaceuticals
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
67 | 3.94% |
| Standard Heparin |
Pharmaceuticals and Active Ingredients for Pharmaceuticals
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
1,184 | 69.61% |
| keyboard_arrow_down |
CDMO
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
92 | 5.41% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||
| keyboard_arrow_down |
Domestic Preparation
Pharmaceuticals and Active Ingredients for Pharmaceuticals
|
358 | 21.05% |
| keyboard_arrow_right |
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
||
| keyboard_arrow_down |
Other
Pharmaceuticals and Active Ingredients for Pharmaceuticals
|
67 | 3.94% |
| keyboard_arrow_right |
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
||
| keyboard_arrow_down |
Standard Heparin
Pharmaceuticals and Active Ingredients for Pharmaceuticals
|
1,184 | 69.61% |
| keyboard_arrow_right |
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
||